Abstract

Remyelination is a regenerative process that is essential to recover saltatory conduction and to prevent neurodegeneration upon demyelination. The formation of new myelin involves the differentiation of oligodendrocyte progenitor cells (OPCs) toward oligodendrocytes and requires high amounts of cholesterol. Astrocytes (ASTRs) modulate remyelination by supplying lipids to oligodendrocytes. Remarkably, remyelination is more efficient in grey matter (GM) than in white matter (WM), which may relate to regional differences in ASTR subtype. Here, we show that a feeding layer of gmASTRs was more supportive to in vitro myelination than a feeding layer of wmASTRs. While conditioned medium from both gmASTRs and wmASTRs accelerated gmOPC differentiation, wmOPC differentiation is enhanced by secreted factors from gmASTRs, but not wmASTRs. In vitro analyses revealed that gmASTRs secreted more cholesterol than wmASTRs. Cholesterol efflux from both ASTR types was reduced upon exposure to pro‐inflammatory cytokines, which was mediated via cholesterol transporter ABCA1, but not ABCG1, and correlated with a minor reduction of myelin membrane formation by oligodendrocytes. Surprisingly, a wmASTR knockdown of Fdft1 encoding for squalene synthase (SQS), an enzyme essential for the first committed step in cholesterol biosynthesis, enhanced in vitro myelination. Reduced secretion of interleukin‐1β likely by enhanced isoprenylation, and increased unsaturated fatty acid synthesis, both pathways upstream of SQS, likely masked the effect of reduced levels of ASTR‐derived cholesterol. Hence, our findings indicate that gmASTRs export more cholesterol and are more supportive to myelination than wmASTRs, but specific inhibition of cholesterol biosynthesis in ASTRs is beneficial for wmASTR‐mediated modulation of myelination.

Highlights

  • Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) characterized by recurring inflammation, loss of oligodendrocytes (OLGs) and myelin, astrogliosis, remyelination failure, and neuronal loss (Compston & Coles, 2008; Reich, Lucchinetti, & Calabresi, 2018)

  • Our findings revealed that the availability of ASTR-derived cholesterol may play a role in oligodendrocyte progenitor cell (OPC) maturation, downregulation of committed cholesterol biosynthesis in wmASTRs but not gmASTRs, unexpectedly led to increased myelination in vitro

  • To examine whether an inhibition of cholesterol synthesis downstream of farnesyl-PP results in an increase in fatty acid synthesis (Figure 2a), the mRNA levels of Srebf1c were examined by quantitative reverse transcriptase PCR (qPCR)

Read more

Summary

| INTRODUCTION

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) characterized by recurring inflammation, loss of oligodendrocytes (OLGs) and myelin, astrogliosis, remyelination failure, and neuronal loss (Compston & Coles, 2008; Reich, Lucchinetti, & Calabresi, 2018). Remyelination proceeds via differentiation of oligodendrocyte progenitor cells (OPCs) to myelinating OLGs. Recent findings indicate that grey matter OPCs (gmOPCs) and white matter OPCs (wmOPCs) intrinsically differ (Lentferink, Jongsma, Werkman, & Baron, 2018; Viganò, Möbius, Götz, & Dimou, 2013). When OLGs are unable to produce cholesterol during CNS development myelin formation is reduced, while there is no difference in the ratio of cholesterol to other lipids incorporated in myelin (Saher et al, 2005). Our findings revealed that the availability of ASTR-derived cholesterol may play a role in OPC maturation, downregulation of committed cholesterol biosynthesis in wmASTRs but not gmASTRs, unexpectedly led to increased myelination in vitro

| MATERIALS AND METHODS
Findings
| DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call